Hollsteen
← Intel

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $61.2B · 10-Q 0000050863-16-000125 filed May 2, 2016Equity incl. NCI · Q2 2016: $61.4B · 10-Q 0000050863-16-000142 filed Aug 1, 2016Equity incl. NCI · Q3 2016: $63.1B · 10-Q 0000050863-16-000153 filed Oct 31, 2016Equity incl. NCI · Q4 2016: $66.2B · 10-K 0000050863-17-000012 filed Feb 17, 2017Equity incl. NCI · Q1 2017: $66.8B · 10-Q 0000050863-17-000029 filed Apr 27, 2017Equity incl. NCI · Q2 2017: $68.6B · 10-Q 0000050863-17-000041 filed Jul 27, 2017Equity incl. NCI · Q3 2017: $70.9B · 10-Q 0000050863-17-000048 filed Oct 26, 2017Equity incl. NCI · Q4 2017: $69.7B · 10-K 0000050863-21-000010 filed Jan 22, 2021Equity incl. NCI · Q1 2018: $70.2B · 10-Q 0000050863-18-000013 filed Apr 27, 2018Equity incl. NCI · Q2 2018: $70.0B · 10-Q 0000050863-18-000022 filed Jul 27, 2018Equity incl. NCI · Q3 2018: $71.5B · 10-Q 0000050863-18-000029 filed Oct 26, 2018Equity incl. NCI · Q4 2018: $74.6B · 10-K 0000050863-19-000007 filed Feb 1, 2019Equity incl. NCI · Q1 2019: $73.7B · 10-Q 0000050863-19-000013 filed Apr 26, 2019Equity incl. NCI · Q2 2019: $74.9B · 10-Q 0000050863-19-000023 filed Jul 26, 2019Equity incl. NCI · Q3 2019: $74.2B · 10-Q 0000050863-19-000029 filed Oct 25, 2019Equity incl. NCI · Q4 2019: $77.5B · 10-K 0000050863-20-000011 filed Jan 24, 2020Equity incl. NCI · Q1 2020: $76.4B · 10-Q 0000050863-20-000017 filed Apr 24, 2020Equity incl. NCI · Q2 2020: $82.0B · 10-Q 0000050863-20-000026 filed Jul 24, 2020Equity incl. NCI · Q3 2020: $74.6B · 10-Q 0000050863-20-000043 filed Oct 23, 2020Equity incl. NCI · Q4 2020: $81.0B · 10-K 0000050863-21-000010 filed Jan 22, 2021Equity incl. NCI · Q1 2021: $79.8B · 10-Q 0000050863-21-000018 filed Apr 23, 2021Equity incl. NCI · Q2 2021: $85.2B · 10-Q 0000050863-21-000030 filed Jul 23, 2021Equity incl. NCI · Q3 2021: $90.1B · 10-Q 0000050863-21-000038 filed Oct 22, 2021Equity incl. NCI · Q4 2021: $95.4B · 10-K 0000050863-22-000007 filed Jan 27, 2022Equity incl. NCI · Q1 2022: $103.1B · 10-Q 0000050863-22-000020 filed Apr 29, 2022Equity incl. NCI · Q2 2022: $101.2B · 10-Q 0000050863-22-000030 filed Jul 29, 2022Equity incl. NCI · Q3 2022: $99.9B · 10-Q 0000050863-22-000038 filed Oct 28, 2022Equity incl. NCI · Q4 2022: $103.3B · 10-K 0000050863-23-000006 filed Jan 27, 2023Equity incl. NCI · Q1 2023: $100.4B · 10-Q 0000050863-23-000028 filed Apr 28, 2023Equity incl. NCI · Q2 2023: $104.5B · 10-Q 0000050863-23-000069 filed Jul 28, 2023Equity incl. NCI · Q3 2023: $105.7B · 10-Q 0000050863-23-000103 filed Oct 27, 2023Equity incl. NCI · Q4 2023: $110.0B · 10-K 0000050863-24-000010 filed Jan 26, 2024Equity incl. NCI · Q1 2024: $110.8B · 10-Q 0000050863-24-000076 filed Apr 26, 2024Equity incl. NCI · Q2 2024: $120.4B · 10-Q 0000050863-24-000124 filed Aug 2, 2024Equity incl. NCI · Q3 2024: $104.9B · 10-Q 0000050863-24-000149 filed Nov 1, 2024Equity incl. NCI · Q4 2024: $105.0B · 10-K 0000050863-25-000009 filed Jan 31, 2025Equity incl. NCI · Q1 2025: $106.4B · 10-Q 0000050863-25-000074 filed Apr 25, 2025Equity incl. NCI · Q2 2025: $105.8B · 10-Q 0000050863-25-000109 filed Jul 24, 2025Equity incl. NCI · Q3 2025: $116.7B · 10-Q 0000050863-25-000179 filed Nov 6, 2025Equity incl. NCI · Q4 2025: $126.4B · 10-K 0000050863-26-000011 filed Jan 23, 2026Equity incl. NCI · Q1 2026: $125.0B · 10-Q 0000050863-26-000079 filed Apr 24, 2026Equity incl. NCI · Q2 2026: $103.1B · 10-Q 0000050863-26-000157 filed Jul 24, 202673.7103.161.2126.4Q1 2016Q2 2026Q1 2019
Q1 2019
73.7$B
All values (42)
PeriodValue ($B)Status
Q2 2026103.1reported
Q1 2026125.0reported
Q4 2025126.4reported
Q3 2025116.7reported
Q2 2025105.8reported
Q1 2025106.4reported
Q4 2024105.0reported
Q3 2024104.9reported
Q2 2024120.4reported
Q1 2024110.8reported
Q4 2023110.0reported
Q3 2023105.7reported
Q2 2023104.5reported
Q1 2023100.4reported
Q4 2022103.3reported
Q3 202299.9reported
Q2 2022101.2reported
Q1 2022103.1reported
Q4 202195.4reported
Q3 202190.1reported
Q2 202185.2reported
Q1 202179.8reported
Q4 202081.0reported
Q3 202074.6reported
Q2 202082.0reported
Q1 202076.4reported
Q4 201977.5reported
Q3 201974.2reported
Q2 201974.9reported
Q1 201973.7reported
Q4 201874.6reported
Q3 201871.5reported
Q2 201870.0reported
Q1 201870.2reported
Q4 201769.7reported
Q3 201770.9reported
Q2 201768.6reported
Q1 201766.8reported
Q4 201666.2reported
Q3 201663.1reported
Q2 201661.4reported
Q1 201661.2reported

CSV with all sources · Technical ID: equity_total

More metrics for Intel
Sources & calculation
Value
$73.7B
Period
Q1 2019, ended Mar 30, 2019 · as of Mar 30, 2019 (balance as of date, not a sum)
Source
10-Q, filed Apr 26, 2019 · 0000050863-19-000013
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$73.7BApr 26, 201910-Q 0000050863-19-000013reported · confidence 1. · current